We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$209M
Cap. Flow
+$62M
Cap. Flow %
4.13%
Top 10 Hldgs %
53.8%
Holding
1,139
New
71
Increased
183
Reduced
145
Closed
36

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$13.8M
2
MSFT icon
Microsoft
MSFT
+$7.37M
3
TMO icon
Thermo Fisher Scientific
TMO
+$6.07M
4
V icon
Visa
V
+$5.18M
5
ADBE icon
Adobe
ADBE
+$3.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.63M
2
AMZN icon
Amazon
AMZN
+$3.19M
3
TSLA icon
Tesla
TSLA
+$1.89M
4
AMD icon
Advanced Micro Devices
AMD
+$1.46M
5
ABT icon
Abbott
ABT
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 21.59%
3 Consumer Discretionary 19.48%
4 Communication Services 10.64%
5 Healthcare 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTV
1076
DELISTED
VERITIV CORPORATION
VRTV
$139 ﹤0.01%
11
SCPX
1077
DELISTED
Scorpius Holdings, Inc.
SCPX
0
MARA icon
1078
Marathon Digital Holdings
MARA
$4.12B
$123 ﹤0.01%
63
GALT icon
1079
Galectin Therapeutics
GALT
$405M
$107 ﹤0.01%
40
XBIO icon
1080
Xenetic Biosciences
XBIO
$9.33M
$96 ﹤0.01%
11
FRO icon
1081
Frontline
FRO
$9.84B
$91 ﹤0.01%
14
AIG.WS
1082
DELISTED
American International Group, Inc.
AIG.WS
$85 ﹤0.01%
531
HYMCZ
1083
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$76 ﹤0.01%
+268
New +$89
GENE
1084
DELISTED
Genetic Technologies Ltd.
GENE
$69 ﹤0.01%
4
BNBX
1085
DELISTED
BNB PLUS CORP
BNBX
0
ELOX
1086
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
BNTC icon
1087
Benitec Biopharma
BNTC
$428M
0
CRIS icon
1088
Curis
CRIS
$3.61M
0
NNVC icon
1089
NanoViricides
NNVC
$31.7M
$31 ﹤0.01%
8
MNK
1090
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$29 ﹤0.01%
30
GLBS icon
1091
Globus Maritime Ltd
GLBS
$76.4M
$22 ﹤0.01%
2
BLRX
1092
BioLineRX
BLRX
$11.4M
0
LSTA icon
1093
Lisata Therapeutics
LSTA
$15.2M
$18 ﹤0.01%
1
FAZ
1094
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
0
TPST icon
1095
Tempest Therapeutics
TPST
$17.5M
0
MBOT icon
1096
Microbot Medical
MBOT
$99.4M
$8 ﹤0.01%
1
GTE icon
1097
Gran Tierra Energy
GTE
$349M
$7 ﹤0.01%
3
GRCE
1098
Grace Therapeutics
GRCE
$44.6M
$6 ﹤0.01%
1
OIBR.C
1099
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$6 ﹤0.01%
4
OPTT icon
1100
Ocean Power Technologies
OPTT
$46.2M
$2 ﹤0.01%
2

Similar funds

RBC Europe's Q3 2020 Portfolio in Review

As of Q3 2020, RBC Europe held 1,139 positions worth $1.5B, up 16% from $1.29B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

RBC Europe deployed $62M of net new capital in Q3 2020, opening 71 new positions and adding to 183 existing holdings. Its largest new stake was Sprott Physical Silver Trust: 31,220 shares worth $258K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $4.63M trimmed.

  • RBC Europe's largest Q3 2020 buy was Sprott Physical Silver Trust: 31,220 shares worth $258K.
  • RBC Europe added most to Applied Materials in Q3 2020, an estimated $13.8M increase.
  • RBC Europe's biggest Q3 2020 reduction was Apple, cutting an estimated $4.63M.
  • RBC Europe fully exited State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2020, selling an estimated $196K.
  • RBC Europe's ten largest holdings make up 54% of its $1.5B portfolio in Q3 2020.
  • RBC Europe opened 71 new positions and closed 36 in Q3 2020.
  • RBC Europe's portfolio value rose 16% quarter-over-quarter to $1.5B.

Based on RBC Europe's 13F filing for Q3 2020, filed 9 Nov 2023.